Treating morbid obesity in cirrhosis: A quest of holy grail - Wikidata - awgldk - TriplyDB

Treating morbid obesity in cirrhosis: A quest of holy grail

Treating morbid obesity in cirrhosis: A quest of holy grail

http://www.wikidata.org/entity/Q26775811

about

Bariatric surgery in individuals with liver cirrhosis: A narrative review.Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients.The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.

P2860

Q39206874-97209935-2CE5-4BA8-A12C-F8F505624E1E Q47971448-711151DB-C406-4D7A-9FF1-741B3AB7E3C2 Q48152092-0356FDE7-0638-4C07-8C5F-FBF1D1E54CD5

P2860

Treating morbid obesity in cirrhosis: A quest of holy grail

http://www.wikidata.org/entity/Q26775811

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Treating morbid obesity in cirrhosis: A quest of holy grail

@ast

Treating morbid obesity in cirrhosis: A quest of holy grail

@en

Treating morbid obesity in cirrhosis: A quest of holy grail

@nl

type

label

Treating morbid obesity in cirrhosis: A quest of holy grail

@ast

Treating morbid obesity in cirrhosis: A quest of holy grail

@en

Treating morbid obesity in cirrhosis: A quest of holy grail

@nl

prefLabel

Treating morbid obesity in cirrhosis: A quest of holy grail

@ast

Treating morbid obesity in cirrhosis: A quest of holy grail

@en

Treating morbid obesity in cirrhosis: A quest of holy grail

@nl

P1433

Q26775811-BDD594EB-223F-4E1A-BC86-97E86C53EC11

P1476

Q26775811-98950E57-F34D-46DF-98CC-910583FEB0F3

P2093

Q26775811-045D7524-089D-4E8D-AC52-2B3452B0FD46

Q26775811-6957EC12-6E7B-48A5-A9E8-F9EDF7DDF5EA

P2860

Q26775811-01AF7FA5-F304-4C75-A9E3-53191B1EFD6F

Q26775811-0E110F9A-2E98-46F9-9BD1-8ACADC198CD9

Q26775811-1708EFBD-23E1-45CE-BEBD-45C3442B950A

Q26775811-19114078-B76E-48EF-8E03-1FA05C199510

Q26775811-1C50D5E5-D2DE-414E-9495-49CF9669BB66

Q26775811-1E24B593-BAE0-4DDE-9AED-6716679EA0B4

Q26775811-1FA6421B-8CD0-4E58-AC5E-774AC38B0F94

Q26775811-28C8768F-8A39-44A3-A9BA-E4A900149761

Q26775811-29EA2C7C-EF3D-486F-B97F-73F612D17ACE

Q26775811-33E3B483-28F9-4B81-AF3F-622A9943FE28

P304

Q26775811-9454287B-7147-479E-A4C5-87B4772A4779

P31

Q26775811-E458AD0F-49EE-422F-BFB3-3E034B4CD297

P356

Q26775811-1F58F01E-B91B-4108-9EA4-D84E464099CF

P407

Q26775811-6DE6AD97-5018-435E-9461-A6DEA1DDAFAE

P433

Q26775811-D37E98FE-6DC4-4E5E-878E-0D290E9B502E

P478

Q26775811-9DB0E644-6428-4279-A949-9039BF3BDE94

P577

Q26775811-DBD62104-E295-44D1-A3FD-853F90F7E0F7

P5875

Q26775811-8654FF50-843A-4B43-A5AF-CB97C2FB3D58

P698

Q26775811-9FC1D339-771E-4B28-AC7F-1493B73DA831

P921

Q26775811-67C1435B-59FB-48B8-A405-ABFD4EF64DD8

P932

Q26775811-89B3A023-CF59-4CF8-BA9D-C1DA2FC476B6

P356

WJH.V7.I28.2819

P1433

World journal of hepatology

P1476

Treating morbid obesity in cirrhosis: A quest of holy grail

@en

P2093

Narendra Singh Choudhary

http://www.w3.org/2001/XMLSchema#string

Naveen Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis

The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012

Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity

Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date

New and emerging drug molecules against obesity.

Myths, presumptions, and facts about obesity.

Trends in mortality in bariatric surgery: a systematic review and meta-analysis.

Pathogenesis of non-alcoholic fatty liver disease.

Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA).

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

P304

2819-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V7.I28.2819

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285728026

http://www.w3.org/2001/XMLSchema#string

P698

26668693

http://www.w3.org/2001/XMLSchema#string

P921

P932

4670953

http://www.w3.org/2001/XMLSchema#string